Keeping Track: Approvals For Genentech And AstraZeneca, CR Letter For Neos, And Breakthrough For Teva
Executive Summary
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Keeping Track: Pre-Independence Day Fireworks Crackle At US FDA With Burst Of Approvals And Filings
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: FDA Hands Out Complete Responses, Expedited Pathway Designations
The latest US drug development news and highlights from our Performance Tracker.
Melanoma Approvals Break New Ground In Immunotherapy
First adjuvant and combination approvals for immuno-oncology could help revive Yervoy in melanoma; Amgen’s oncolytic cancer vaccine emerges as new mechanism for select patients, with room to grow.